These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356 [TBL] [Abstract][Full Text] [Related]
4. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents]. Boutaud P; Guillem JP; Maarek-Charbit M; Amiel A; Ciber M; Herpin D; Demange J Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):37-42. PubMed ID: 2930150 [TBL] [Abstract][Full Text] [Related]
5. [Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone]. Bianconi L; Boccadamo R; Pappalardo A; Broglia R; Pistolese M G Ital Cardiol; 1987 Aug; 17(8):653-60. PubMed ID: 3692070 [TBL] [Abstract][Full Text] [Related]
6. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872 [TBL] [Abstract][Full Text] [Related]
7. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial. Madonia S; De Simone M; Brai G; Gozzo D; Gristina A; Luciano L; Maisano S; Migliore G; Mineo R; Muzzo MP; Nicchi F; Randazzo A; Raspanti G; Rotolo G; Russo A; Sagona F; Schirosa M; Spinello M; Stancampiano R; Geraci E Ital Heart J; 2000 Jul; 1(7):475-9. PubMed ID: 10933330 [TBL] [Abstract][Full Text] [Related]
8. Propafenone: a new antiarrhythmic agent. Chow MS; Lebsack C; Hilleman D Clin Pharm; 1988 Dec; 7(12):869-77. PubMed ID: 3061720 [TBL] [Abstract][Full Text] [Related]
9. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161 [TBL] [Abstract][Full Text] [Related]
10. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation]. Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684 [TBL] [Abstract][Full Text] [Related]
11. [Propafenone efficacy in preventing supraventricular tachycardia in childhood]. Bodegas A; Cabrera A; Sarrionaindía MJ; Idígoras G; Rumoroso JR; Pérez García P; Pastor E; Galdeano JM; Sota J; Barrenetxea JI Rev Esp Cardiol; 1994 Feb; 47(2):86-91. PubMed ID: 8165353 [TBL] [Abstract][Full Text] [Related]
12. [The efficacy of intravenous propafenone and amiodarone in the conversion of recent-onset atrial fibrillation. A 1-year follow-up with oral treatment]. Bellandi F; Cantini F; Pedone T; Dabizzi RP; Palchetti R G Ital Cardiol; 1993 Mar; 23(3):261-71. PubMed ID: 8325461 [TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group. Podrid PJ; Anderson JL Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188 [TBL] [Abstract][Full Text] [Related]
14. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873 [TBL] [Abstract][Full Text] [Related]
15. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study]. Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393 [TBL] [Abstract][Full Text] [Related]
16. [Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone]. Boriani G; Capucci A; Strocchi E; Marchesini B; Baroni M; Frabetti L; Ambrosioni E; Magnani B G Ital Cardiol; 1991 May; 21(5):517-26. PubMed ID: 1936756 [TBL] [Abstract][Full Text] [Related]
17. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review. Hughes C; Sunderji R; Gin K Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses]. Lardoux H; Valère PE; Djiane P; Maarek-Charbit M Ann Cardiol Angeiol (Paris); 1993 May; 42(5):281-8. PubMed ID: 7690219 [TBL] [Abstract][Full Text] [Related]
19. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique]. Li Q; Wang Z; Peng D Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]